Lv42
458 积分 2024-07-02 加入
Changing for the Better: Discovery of the Highly Potent and Selective CDK9 Inhibitor VIP152 Suitable for Once Weekly Intravenous Dosing for the Treatment of Cancer
3小时前
待确认
Abstract 1218: CDK9 inhibitors modulate the transcriptional landscape of colorectal cancer to suppress MAPK signaling and synergizes with BRAF inhibitors to treat BRAF-mutant colorectal cancer
20小时前
已完结
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders
4天前
已完结
Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury
1个月前
已完结
Mouse Model of Staphylococcus aureus Skin Infection
2个月前
已完结
Isolation and Characterization of Two Antimicrobial Agents from Mace (Myristica fragrans)
2个月前
已完结
Agents that increase the permeability of the outer membrane
2个月前
已关闭
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2个月前
已完结
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples
2个月前
已完结
Detection of Mycoplasma in cell cultures
3个月前
已完结
皖公网安备34019202002308
